spacer
spacer

PDBsum entry 4x2k

Go to PDB code: 
protein ligands links
Transferase PDB id
4x2k

 

 

 

 

Loading ...

 
JSmol PyMol  
Contents
Protein chain
303 a.a.
Ligands
3WO
SO4
Waters ×250
PDB id:
4x2k
Name: Transferase
Title: Selection of fragments for kinase inhibitor design: decoration is key
Structure: Tgf-beta receptor type-1. Chain: a. Synonym: tgfr-1,activin a receptor type ii-like protein kinase of 53kd,activin receptor-like kinase 5,alk5,serine/threonine-protein kinase receptor r4,skr4,tgf-beta type i receptor,transforming growth factor-beta receptor type i,tbetar-i. Engineered: yes
Source: Homo sapiens. Human. Organism_taxid: 9606. Gene: tgfbr1, alk5, skr4. Expressed in: spodoptera frugiperda. Expression_system_taxid: 7108
Resolution:
1.69Å     R-factor:   0.167     R-free:   0.184
Authors: P.Czodrowski,G.Hoelzemann,G.Barnickel,H.Greiner,D.Musil
Key ref: P.Czodrowski et al. (2015). Selection of fragments for kinase inhibitor design: decoration is key. J Med Chem, 58, 457-465. PubMed id: 25437144 DOI: 10.1021/jm501597j
Date:
26-Nov-14     Release date:   24-Dec-14    
PROCHECK
Go to PROCHECK summary
 Headers
 References

Protein chain
Pfam   ArchSchema ?
P36897  (TGFR1_HUMAN) -  TGF-beta receptor type-1 from Homo sapiens
Seq:
Struc:
503 a.a.
303 a.a.*
Key:    PfamA domain  Secondary structure  CATH domain
* PDB and UniProt seqs differ at 1 residue position (black cross)

 Enzyme reactions 
   Enzyme class: E.C.2.7.11.30  - receptor protein serine/threonine kinase.
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
      Reaction:
1. L-seryl-[receptor-protein] + ATP = O-phospho-L-seryl-[receptor- protein] + ADP + H+
2. L-threonyl-[receptor-protein] + ATP = O-phospho-L-threonyl-[receptor- protein] + ADP + H+
L-seryl-[receptor-protein]
+ ATP
= O-phospho-L-seryl-[receptor- protein]
+ ADP
+ H(+)
L-threonyl-[receptor-protein]
+ ATP
= O-phospho-L-threonyl-[receptor- protein]
+ ADP
+ H(+)
Molecule diagrams generated from .mol files obtained from the KEGG ftp site

 

 
    reference    
 
 
DOI no: 10.1021/jm501597j J Med Chem 58:457-465 (2015)
PubMed id: 25437144  
 
 
Selection of fragments for kinase inhibitor design: decoration is key.
P.Czodrowski, G.Hölzemann, G.Barnickel, H.Greiner, D.Musil.
 
  ABSTRACT  
 
In fragment-based screening, the choice of the best suited fragment hit among the detected hits is crucial for success. In our study, a kinase lead compound was fragmented, the hinge-binding motif extracted as a core fragment, and a minilibrary of five similar compounds with fragment-like properties was selected from our proprietary compound database. The structures of five fragments in complex with transforming growth factor β receptor type 1 kinase domain were determined by X-ray crystallography. Three different binding modes of the fragments are observed that depend on the position and the type of the substitution at the core fragment. The influence of different substituents on the preferred fragment pose was analyzed by various computational approaches. We postulate that the replacement of water molecules leads to the different binding modes.
 

 

spacer

spacer